SPXV:ARCA-ProShares S&P 500 Ex-Health Care (USD)

ETF | Large Blend | NYSE Arca

Last Closing

USD 54.2178

Change

0.00 (0.00)%

Market Cap

USD 1.15M

Volume

416.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks investment results, before fees and expenses that track the performance of the S&P 500? Ex-Health Care Index (the "index"). Under normal circumstances, the fund will invest at least 80% of its total assets in component securities. The index seeks to provide exposure to the companies of the S&P 500? Index (the "S&P 500?") with the exception of those companies included in the Health Care Sector.

Inception Date: 22/09/2015

Primary Benchmark: S&P 500 Ex-Health Care USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.27%

Management Expense Ratio: 0.27 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-28 )

Largest Industry Peers for Large Blend

Symbol Name Mer Price(Change) Market Cap
SPY SPDR S&P 500 ETF Trust 0.09 %

+6.48 (+1.24%)

USD 510.94B
IVV iShares Core S&P 500 ETF 0.04 %

+6.52 (+1.24%)

USD 455.09B
VOO Vanguard S&P 500 ETF 0.03 %

+5.86 (+1.22%)

USD 444.68B
VTI Vanguard Total Stock Market In.. 0.03 %

+3.19 (+1.23%)

USD 390.30B
VIG Vanguard Dividend Appreciation.. 0.06 %

+1.95 (+1.07%)

USD 77.23B
RSP Invesco S&P 500® Equal Weight.. 0.20 %

+1.33 (+0.80%)

USD 55.86B
ITOT iShares Core S&P Total U.S. St.. 0.03 %

+1.45 (+1.26%)

USD 54.16B
SCHX Schwab U.S. Large-Cap ETF 0.03 %

+0.79 (+1.27%)

USD 39.95B
IWB iShares Russell 1000 ETF 0.15 %

+3.60 (+1.25%)

USD 35.14B
VV Vanguard Large-Cap Index Fund .. 0.04 %

+3.11 (+1.30%)

USD 34.45B

ETFs Containing SPXV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Large Blend) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.76% 84% B 78% C+
Dividend Return 0.29% 30% F 15% F
Total Return 8.05% 85% B 76% C+
Trailing 12 Months  
Capital Gain 25.45% 89% A- 81% B-
Dividend Return 1.48% 46% F 20% F
Total Return 26.94% 89% A- 80% B-
Trailing 5 Years  
Capital Gain 75.24% 84% B 83% B
Dividend Return 8.33% 66% D+ 30% F
Total Return 83.57% 86% B+ 83% B
Average Annual (5 Year Horizon)  
Capital Gain 13.27% 84% B 77% C+
Dividend Return 14.60% 82% B 76% C+
Total Return 1.33% 69% C- 32% F
Risk Return Profile  
Volatility (Standard Deviation) 19.35% 36% F 58% F
Risk Adjusted Return 75.45% 69% C- 93% A
Market Capitalization 1.15M 4% F 10% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.